Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank33
3Y CAGR-36.1%
5Y CAGR+1.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-36.1%/yr
Annual compound
5Y CAGR
+1.0%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $26.70M | -33.6% |
| 2024 | $40.23M | -24.8% |
| 2023 | $53.50M | -47.8% |
| 2022 | $102.53M | -36.3% |
| 2021 | $160.92M | +532.5% |
| 2020 | $25.44M | +1259.1% |
| 2019 | $1.87M | - |